Status:
COMPLETED
Preventing Isthmocele After Cesarean Section
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Cesarean Section Complications
Uterine Scar Diverticulum
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Cesarean section accounts for nearly 30% of births in Canada, and is the most commonly performed surgery by Obstetrician Gynecologists. Cesarean scar isthmocele, meaning a defect in the uterine wall a...
Detailed Description
Cesarean section accounts for nearly 30% of all deliveries in Canada, and is the most commonly performed surgery by Obstetrician Gynecologists (OBGYNs) in Canada. Therefore, it is important to underst...
Eligibility Criteria
Inclusion
- Women undergoing their first cesarean section
Exclusion
- previous uterine hysterotomy (caesarean section, myomectomy, etc.)
- known uterine anomalies
- active labour
- known bleeding disorder
- maternal connective tissue disorders
Key Trial Info
Start Date :
March 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03826459
Start Date
March 5 2019
End Date
December 18 2020
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G1Z5